...
首页> 外文期刊>Fish & Shellfish Immunology >Immunogenicity of Lactobacillus-expressing VP2 and VP3 of the infectious pancreatic necrosis virus (IPNV) in rainbow trout.
【24h】

Immunogenicity of Lactobacillus-expressing VP2 and VP3 of the infectious pancreatic necrosis virus (IPNV) in rainbow trout.

机译:虹鳟鱼中表达乳酸杆菌VP2和VP3的传染性胰腺坏死病毒(IPNV)的免疫原性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Infectious pancreatic necrosis virus (IPNV) infects salmonid fish with high mortality and causes serious economic losses to salmonid aquaculture. Lactobacillus strains have a number of properties that make them attractive candidates as delivery vehicles for the presentation to the mucosa of compounds with pharmaceutical interest, in particular vaccines. Here, Lactobacilli/Escherichia coli shuttle vector pPG1 (surface-displayed) or pPG2 (secretory) with the capsid VP2 gene inserted was transformed into Lactobacillus casei to yield two recombinant strains: Lc:PG1-VP2 and Lc:PG2-VP2, respectively. Rainbow trout immunized respectively with Lc:PG1-VP2, Lc:PG2-VP2, Lc:PG1-VP3 and Lc:PG2-VP3 elicited anti-IPNV immune responses (serum IgM) via oral route. Statistical results of serum IgM titer with neutralizing activity showed that immunogenicity of Lc:PG2-VP2 was more powerful than that of Lc:PG1-VP2 (P<0.001), Lc:PG1-VP3 (P<0.001) and Lc:PG2-VP3 (P<0.001), which was confirmed by viral loads reduction analyzed by real-time RT-PCR in orally immunized rainbow trout after virus challenge. Comparing with negative control, rainbow trout orally dosed with Lc:PG2-VP2 resulted in ~46-fold reduction in virus load on days 10 post viral challenge as well as Lc:PG1-VP2(~20-fold), Lc:PG2-VP3(~6-fold) and Lc:PG1-VP3(~3-fold). Taken together, Lc:PG2-VP2 exhibited a more appropriate candidate as live bacteria vaccine against IPNV infection in rainbow trout.Digital Object Identifier http://dx.doi.org/10.1016/j.fsi.2011.11.015
机译:传染性胰腺坏死病毒(IPNV)以高死亡率感染鲑鱼,并给鲑鱼养殖造成严重的经济损失。乳酸杆菌菌株具有许多特性,使其成为有吸引力的候选药物,成为将具有药用价值的化合物,特别是疫苗呈递至粘膜的递送载体。在这里,将插入衣壳VP2基因的乳酸杆菌/大肠杆菌穿梭载体pPG1(表面展示)或pPG2(分泌的)转化入干酪乳杆菌,以产生两种重组菌株: Lc:PG1-VP2和Lc:PG2-VP2。分别用Lc:PG1-VP2,Lc:PG2-VP2,Lc:PG1-VP3和Lc:PG2-VP3免疫的虹鳟鱼经口服途径引发抗IPNV免疫应答(血清IgM)。具有中和活性的血清IgM滴度的统计结果表明,Lc:PG2-VP2的免疫原性比Lc:PG1-VP2( P <0.001),Lc:PG1-VP3( P <0.001)和Lc:PG2-VP3( P <0.001),通过实时RT-PCR分析病毒感染后口服虹鳟的病毒载量减少得到证实挑战。与阴性对照相比,口服Lc:PG2-VP2的虹鳟鱼在病毒攻击后第10天以及Lc:PG1-VP2,Lc:PG2-的病毒载量减少了46倍左右(〜20倍) VP3(〜6倍)和Lc:PG1-VP3(〜3倍)。综上所述,Lc:PG2-VP2作为针对虹鳟鱼IPNV感染的活菌疫苗展示了更合适的候选物。数字对象标识符http://dx.doi.org/10.1016/j.fsi.2011.11.015

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号